Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity

NCT00999908 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Indacaterol 150 μg
DRUG: Tiotropium 18 μg
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals